Reliable XAI Explanations in Sudden Cardiac Death Prediction for Chagas Cardiomyopathy
Organizations: Federal Institute of Education and Technology of Ceara, Maracanau, Ceara, Brazil · Universidade Feferal do Ceará (UFC), CE · Edson Saad Heart Institute – Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Abstract
Sudden cardiac death (SCD) is unpredictable, and its prediction in Chagas cardiomyopathy (CC) remains a significant challenge, especially in patients not classified as high risk. While AI and machine learning models improve risk stratification, their adoption is hindered by a lack of transparency, as they are often perceived as black boxes with unclear decision-making processes. Some approaches apply heuristic explanations without correctness guarantees, leading to mistakes in the decision-making process. To address this, we apply a logic-based explainability method with correctness guarantees to the problem of SCD prediction in CC. This explainability method, applied to an AI classifier with over 95% accuracy and recall, demonstrated strong predictive performance and 100% explanation fidelity. When compared to state-of-the-art heuristic methods, it showed superior consistency and robustness. This approach enhances clinical trust, facilitates the integration of AI-driven tools into practice, and promotes large-scale deployment, particularly in endemic regions where it is most needed.
Figures & tables
| Group | Qnt. | Features |
|---|---|---|
| Top 10 | 10 | EVTotal; NSVT (mean duration); LVEDV; LA diameter; EF Teicholz; Rassi score (points); LVESV; TSH; Dyslipidemia (DLP); Amiodarone |
| Top 20 | 20 | Top 10 + Holter Age; Stroke.1; ESV; NYHA Class I; HR; Rassi score_low; Sex; LVEF; Mean HR; Stroke |
| Positive Importance | 48 | Top 20 + Syncope; NYHA Class II; BMI; Diastolic Dysfunction_1.0; Classification_Moderate Dysfunction; Guideline 2005_B1; Type 2 Diabetes (DM2); Diastolic Dysfunction_2.0; Ventricular Ectopy (VE); Rassi score_intermediate; Hypertension (HTN); Sedentary lifestyle; Guideline 2005_B2; Coronary artery disease; Classification_Normal; Primary Alteration; Inactive Electrical Area; VE.1; Classification_Mild Dysfunction; ICD (Implantable Defibrillator); Heart Failure; Chronic Kidney Disease; NSVT; Segmental Deficit; AV Conduction Disturbance.1_0.0; Pulmonary Venous Doppler (PVD); Atrial Fibrillation/Flutter; Sinoatrial Node Dysfunction |
| Zero Importance | 15 | AFib/Atrial Flutter; Smoking; Pacemaker; Cancer; Pause > 3s; Guideline 2005_A; Ablations; AV Conduction Disturbance.1_1.0; AV Conduction Disturbance_3.0; AV Conduction Disturbance_2.0; AV Conduction Disturbance_1.0; AV Conduction Disturbance_0.0; Diastolic Dysfunction_0.0; Diastolic Dysfunction_3.0; NYHA Class III |
| Features | Accuracy | Recall | Precision | F1-score | ROC AUC |
|---|---|---|---|---|---|
| All (63) | 0.92 0.04 | 0.85 0.14 | 0.74 0.16 | 0.78 0.13 | 0.89 0.08 |
| Positive (48) | 0.94 0.037 | 0.90 0.137 | 0.78 0.14 | 0.83 0.11 | 0.92 0.07 |
| Top 20 | 0.95 0.03 | 0.95 0.11 | 0.81 0.18 | 0.86 0.09 | 0.95 0.05 |
| Top 10 | 0.92 0.05 | 0.78 0.22 | 0.74 0.18 | 0.76 0.19 | 0.87 0.12 |
| Method | Class | Samples | Synthetic | Exp. Size | Fidelity(%) | Time(s) |
|---|---|---|---|---|---|---|
| Anchors | 0 | 101 | 100 | |||
| 1 | 19 | 100 | ||||
| Lime | 0 | 101 | 100 | |||
| 1 | 19 | 100 | ||||
| Logic-based | 0 | 101 | 100 | |||
| 1 | 19 | 100 |
| Sample | Class | Explanation |
|---|---|---|
| 1 | High risk | LA diameter = 4.5, LVEDV = 5.8, EVTotal = 11094 |
| 2 | High risk | LVEDV = 5.8, EVTotal = 13812, NSVT (mean duration) = 1 |
| 3 | Low risk | LVEDV = 4.4, EF Teicholz = 0.64, Rassi score (points) = 3, Stroke = 0, EVTotal = 1589, NSVT (mean duration) = 0 |
| 4 | Low risk | LVEDV = 4.3, EF Teicholz = 0.68, Rassi score (points) = 2, Stroke = 0, EVTotal = 236, NSVT (mean duration) = 0 |
| Rank | Feature | Count in Explanations | Feature Importance |
|---|---|---|---|
| 1 | EVTotal | 119 | 0.2488 |
| 2 | LVEDV | 114 | 0.0413 |
| 3 | NSVT Holter | 113 | 0.2756 |
| 4 | Stroke | 103 | 0.0608 |
| 5 | Rassi Score(points) | 97 | 0.0492 |
| 6 | TSH | 87 | 0.0488 |
Clinical Risk Prediction
Clinical risk prediction estimates patients’ future health outcomes from medical records, physiological signals, imaging, and other health data.
See all 214 papers